AGM
MDGL icon

Alpine Global Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Alpine Global Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24M Buy
+6,033
New +$3.09M 0.53% 24
2016
Q3 		– Sell
-5,517
Closed -$50K – 138
2016
Q2 		$50K Buy
+5,517
New +$66.2K 0.02% 170

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alpine Global Management's MDGL Position: Q2 2026 in Review

Alpine Global Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 6,033 shares worth $3.24M. The stake represents 0.53% of the portfolio and ranks #24 among its holdings. This is a return to the name: Alpine Global Management previously reported a position in MDGL as recently as Q2 2016.

Alpine Global Management first reported a position in MDGL in Q2 2016 and has held it in 2 quarters since. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Alpine Global Management held 6,033 shares of Madrigal Pharmaceuticals worth $3.24M as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Alpine Global Management position in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.53% of Alpine Global Management's portfolio in Q2 2026, its #24 holding.
  • Alpine Global Management first reported a position in Madrigal Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Alpine Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.